82009-158-22 : NDC 2026 Code

82009-158-22 : Adalimumab-ryvk ( Adalimumab-ryvk )

Additionally :

You can get information about “82009-158-22” NDC code in 82009-158-22 in HTML format

HTML | 82009-158-22 in TXT (Plain Text) format

TXT | 82009-158-22 in PDF (Portable Document Format)

PDF | 82009-158-22 in XML format

XML formats.

NDC Code : 82009-158-22 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "82009-158-22",
    "PackageDescription": "2 KIT in 1 CARTON (82009-158-22)  / 1 KIT in 1 KIT *  1 SYRINGE in 1 TRAY (82009-159-11)  / .4 mL in 1 SYRINGE *  .4 mL in 1 POUCH",
    "NDC11Code": "82009-0158-22",
    "ProductNDC": "82009-158",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Adalimumab-ryvk",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Adalimumab-ryvk",
    "DosageFormName": "KIT",
    "RouteName": "SUBCUTANEOUS",
    "StartMarketingDate": "20240731",
    "EndMarketingDate": null,
    "MarketingCategoryName": "BLA",
    "ApplicationNumber": "BLA761299",
    "LabelerName": "Quallent Pharmaceuticals Health LLC",
    "SubstanceName": null,
    "StrengthNumber": null,
    "StrengthUnit": null,
    "Pharm_Classes": null,
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2026-01-21",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20271231",
    "StartMarketingDatePackage": "20240731",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}